Article
Correlation of LOXL2 expression in non-small cell lung cancer with immunotherapy and clinical prognosis
2023-04-11
Abstract excerpt
<h4>Background: </h4> Lung cancer is the worst and deadliest disease globally, with about 80% of cases being non-small cell lung cancer (NSCLC). NSCLC mainly consists of lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD). Although chemotherapy is currently the mainstay of treatment for NSCLC, chemotherapy resistance is still an urgent problem for patients. Studies in recent years have proposed immu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 129e12e7-92a7-53b6-8be0-442e31c364d5
- DOI
- 10.21203/rs.3.rs-2756606/v1
